Clinical study on preoperative core needle biopsy of breast cancer and detection of ER、PR、C-erbB-2、Ki-67

Gao Hai-dong

2011-01-01

Abstract:Objective: Study the clinical value of preoperative core needle biopsy(CNB) immunohistochemistry diagnosis of breast cancer.Methods: Thirty-five cases diagnosed breast cancer were collected,after resect the tumor we took the core needle biopsy as inimation of core needle biopsy before surgery.Compare the immunohistochemistry diagnosis between the core needle biopsy tissues and the resected tumor tissues.Results: There is no difference on PR、C-erbB-2 and Ki-67 expression between the core needle biopsy tissues and the resected tumors(P0.05)in 35 cases.The staining intensity of ER is different,there is more ER expression in core needle biopsy tissues than the resected tumor tissues,but no difference in qualitative diagnosis(P0.05,Kappar=0.8135).Conclusion: Breast cancer core needle biopsy preoperation is accurately in the immunohistochemistry diagnosis of ER,PR,C-erbB-2 and Ki-67.But ER staining intensity is usually stronger in core needle biopsy tissues than in the resected tumor tissues.So,in the research of the neoadjuvant chemotherapy or endocrine therapy effection on ER expression by comparing the ER expression between the core needle biopsy tissues and the resected tumor tissues,the primary difference must be pay enough attention.